Amelioration of diabetic retinopathy in db/db mice by treatment with different proportional three active ingredients from Tibetan medicine Berberis dictyophylla F

Rui Li,Xiaopeng Ai,Ya Hou,Xianrong Lai,Xianli Meng,Xiaobo Wang

DOI: https://doi.org/10.1016/j.jep.2021.114190

IF: 5.195

2021-08-01

Journal of Ethnopharmacology

Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Berberis dictyophylla F., a famous Tibetan medicine, has been used to prevent and treat diabetic retinopathy (DR) for thousands of years in clinic. However, its underlying mechanisms remain unclear.AIM OF THE STUDY: The present study was designed to probe the synergistic protection and involved mechanisms of berberine, magnoflorine and berbamine from Berberis dictyophylla F. on the spontaneous retinal damage of db/db mice.MATERIALS AND METHODS: The 14-week spontaneous model of DR in db/db mice were randomly divided into eight groups: model group, calcium dobesilate (CaDob, 0.23 g/kg) group and groups 1-6 (different proportional three active ingredients from Berberis dictyophylla F.). All mice were intragastrically administrated for a continuous 12 weeks. Body weight and fasting blood glucose (FBG) were recorded and measured. Hematoxylin-eosin and periodic acid-Schiff (PAS) stainings were employed to evaluate the pathological changes and abnormal angiogenesis of the retina. ELISA was performed to assess the levels of IL-6, HIF-1α and VEGF in the serum. Immunofluorescent staining was applied to detect the protein levels of CD31, VEGF, p-p38, p-JNK, p-ERK and NF-κB in retina. In addition, mRNA expression levels of VEGF, Bax and Bcl-2 in the retina were monitored by qRT-PCR analysis.RESULTS: Treatment with different proportional three active ingredients exerted no significant effect on the weight, but decreased the FBG, increased the number of retinal ganglionic cells and restored internal limiting membrane. The results of PAS staining demonstrated that the drug treatment decreased the ratio of endothelial cells to pericytes while thinned the basal membrane of retinal vessels. Moreover, these different proportional active ingredients can markedly downregulate the protein levels of retinal CD31 and VEGF, and serum HIF-1α and VEGF. The gene expression of retinal VEGF was also suppressed. The levels of retinal p-p38, p-JNK and p-ERK proteins were decreased by drug treatment. Finally, drug treatment reversed the proinflammatory factors of retinal NF-κB and serum IL-6, and proapoptotic Bax gene expression, while increased antiapoptotic Bcl-2 gene expression.CONCLUSIONS: These results indicated that DR in db/db mice can be ameliorated by treatment with different proportional three active ingredients from Berberis dictyophylla F. The potential vascular protection mechanisms may be involved in inhibiting the phosphorylation of the MAPK signaling pathway, thus decreasing inflammatory and apoptotic events.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the synergistic protective effects and potential mechanisms of three active ingredients (berberine, mangiferin, and coptisine) extracted from Tibetan medicine Coptis chinensis on spontaneous diabetic retinopathy (DR) in db/db mice at different ratios. Specifically, the study aims to experimentally verify whether these components can improve the symptoms of diabetic retinopathy, such as reducing retinal vascular abnormal proliferation, inflammatory response, and apoptosis, and to investigate whether their mechanism of action is related to the inhibition of MAPK signaling pathway phosphorylation.

The research background points out that diabetic retinopathy is one of the major microvascular complications of diabetes, which can lead to vision impairment and non-traumatic blindness. Current treatment methods include laser photocoagulation, vitrectomy, and anti-VEGF drug injections, but these methods have certain side effects. Therefore, finding new effective treatment methods is of great significance. Tibetan medicine Coptis chinensis has been used in traditional Tibetan medicine to treat diabetic retinopathy, but its specific mechanism is still unclear. This study systematically evaluated the combined therapeutic effects of different ratios of berberine, mangiferin, and coptisine by establishing a db/db mouse model, providing scientific evidence for the application of Tibetan medicine Coptis chinensis in diabetic retinopathy.